143 related articles for article (PubMed ID: 16084097)
21. Synthesis and preliminary bioevaluation of novel E-ring modified acetal analog of camptothecin as cytotoxic agents.
Zhu L; Zhuang C; Lei N; Guo Z; Sheng C; Dong G; Wang S; Zhang Y; Yao J; Miao Z; Zhang W
Eur J Med Chem; 2012 Oct; 56():1-9. PubMed ID: 23084702
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antitumor activity of 20(S)-camptothecin derivatives: carbamate-linked, water-soluble derivatives of 7-ethyl-10-hydroxycamptothecin.
Sawada S; Okajima S; Aiyama R; Nokata K; Furuta T; Yokokura T; Sugino E; Yamaguchi K; Miyasaka T
Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1446-50. PubMed ID: 1934165
[TBL] [Abstract][Full Text] [Related]
23. Prodrug analogues of the antitumor alkaloid camptothecin.
Adamovics JA; Hutchinson CR
J Med Chem; 1979 Mar; 22(3):310-4. PubMed ID: 423214
[No Abstract] [Full Text] [Related]
24. Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice.
Plowman J; Narayanan VL; Dykes D; Szarvasi E; Briet P; Yoder OC; Paull KD
Cancer Treat Rep; 1986 May; 70(5):631-5. PubMed ID: 3708611
[TBL] [Abstract][Full Text] [Related]
25. Chemical modification of an antitumor alkaloid camptothecin: synthesis and antitumor activity of 7-C-substituted camptothecins.
Sawada S; Nokata K; Furuta T; Yokokura T; Miyasaka T
Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2574-80. PubMed ID: 1806276
[TBL] [Abstract][Full Text] [Related]
26. [Inhibition of hydroxycamptothecin on laryngeal squamous carcinoma cell line].
Chai LP; Su ZZ; Xian ZX
Ai Zheng; 2003 Apr; 22(4):372-5. PubMed ID: 12703991
[TBL] [Abstract][Full Text] [Related]
27. A new antitumour agent, batracylin, selected by a preclinical solid tumour model.
Atassi G; Dumont P; Kabbe HJ; Yoder O
Drugs Exp Clin Res; 1988; 14(9):571-4. PubMed ID: 3229319
[TBL] [Abstract][Full Text] [Related]
28. Combination treatment with Rhizoma Paridis and Rhizoma Curcuma longa extracts and 10-hydroxycamptothecin enhances the antitumor effect in H22 tumor model by increasing the plasma concentration.
Liu Z; Li H; Fan Y; Liu Y; Man S; Yu P; Gao W
Biomed Pharmacother; 2016 Oct; 83():627-634. PubMed ID: 27459119
[TBL] [Abstract][Full Text] [Related]
29. 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice.
Zhang L; Yang M; Wang Q; Li Y; Guo R; Jiang X; Yang C; Liu B
J Control Release; 2007 Jun; 119(2):153-62. PubMed ID: 17400320
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological assays of E-ring analogs of camptothecin and homocamptothecin.
Tangirala RS; Antony S; Agama K; Pommier Y; Anderson BD; Bevins R; Curran DP
Bioorg Med Chem; 2006 Sep; 14(18):6202-12. PubMed ID: 16793274
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antitumor activity of the hexacyclic camptothecin derivatives.
Gao H; Zhang X; Chen Y; Shen H; Pang T; Sun J; Xu C; Ding J; Li C; Lu W
Bioorg Med Chem Lett; 2005 Jul; 15(13):3233-6. PubMed ID: 15913996
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antitumor activity of quaternary salts of 2-(2'-oxoalkoxy)-9-hydroxyellipticines.
Harada N; Kawaguchi T; Inoue I; Ohashi M; Oda K; Hashiyama T; Tsujihara K
Chem Pharm Bull (Tokyo); 1997 Jan; 45(1):134-7. PubMed ID: 9023975
[TBL] [Abstract][Full Text] [Related]
33. Curcumin and docosahexaenoic acid block insulin-induced colon carcinoma cell proliferation.
Fenton JI; McCaskey SJ
Prostaglandins Leukot Essent Fatty Acids; 2013 Mar; 88(3):219-26. PubMed ID: 23266210
[TBL] [Abstract][Full Text] [Related]
34. Comparative molecular field analysis of in vitro growth inhibition of L1210 and HCT-8 cells by some pyrazoloacridines.
Horwitz JP; Massova I; Wiese TE; Wozniak AJ; Corbett TH; Sebolt-Leopold JS; Capps DB; Leopold WR
J Med Chem; 1993 Nov; 36(23):3511-6. PubMed ID: 8280289
[TBL] [Abstract][Full Text] [Related]
35. Syntheses and biological evaluation of vinblastine congeners.
Kuehne ME; Bornmann WG; Markó I; Qin Y; LeBoulluec KL; Frasier DA; Xu F; Mulamba T; Ensinger CL; Borman LS; Huot AE; Exon C; Bizzarro FT; Cheung JB; Bane SL
Org Biomol Chem; 2003 Jun; 1(12):2120-36. PubMed ID: 12945903
[TBL] [Abstract][Full Text] [Related]
36. 7-Cycloalkylcamptothecin derivatives: Preparation and biological evaluation.
Li M; Jin W; Jiang C; Zheng C; Tang W; You T; Lou L
Bioorg Med Chem Lett; 2009 Aug; 19(15):4107-9. PubMed ID: 19541483
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of in vivo antitumor activity of classical anticancer agents by combination with the new, glutathione-interacting DNA minor groove-binder, brostallicin.
Sabatino MA; Colombo T; Geroni C; Marchini S; Broggini M
Clin Cancer Res; 2003 Nov; 9(14):5402-8. PubMed ID: 14614026
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antitumor activity of A-ring modified hexacyclic analogues of camptothecin.
Li DZ; Wang CY; Pan XD; Liu HY; Fu ZD; Wu S
Yao Xue Xue Bao; 2005 Mar; 40(3):241-7. PubMed ID: 15952596
[TBL] [Abstract][Full Text] [Related]
39. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
[TBL] [Abstract][Full Text] [Related]
40. Self-assembling peptide of D-amino acids boosts selectivity and antitumor efficacy of 10-hydroxycamptothecin.
Liu J; Liu J; Chu L; Zhang Y; Xu H; Kong D; Yang Z; Yang C; Ding D
ACS Appl Mater Interfaces; 2014 Apr; 6(8):5558-65. PubMed ID: 24660962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
